First in Human Study of TORL-1-23 in Participants With Advanced Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
First in Human Study of TORL-1-23 in Participants With Advanced Cancer	Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, ovarian cancer, ovarian disorder, uterine disorder	Recruiting	Phase 1	2026-02-13		NCT05103683

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
TORL Biotherapeutics, LLC	8
Translational Research in Oncology	9

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Asan Medical Center	Seoul	South Korea	338
Cleveland Clinic	Cleveland	United States	558
Mayo Clinic in Rochester	Rochester	United States	687
Memorial Sloan Kettering Cancer Center	New York	United States	1000
Providence Medical Foundation	Fullerton	United States	46
Samsung Medical Center	Seoul	South Korea	375
Sarah Cannon Research Institute Texas Oncology	Tyler	United States	1
Seoul National University Hospital	Seoul	South Korea	393
Severance Hospital	Seoul	South Korea	1
St. Vincent's Hospital, The Catholic University of Korea	Suwon	South Korea	1
UCLA - JCCC Clinical Research Unit	Los Angeles	United States	6
University of Kentucky Medical Center	Lexington	United States	23
University of Minnesota	Minneapolis	United States	325
Virginia Cancer Specialists	Fairfax	United States	109